In general, people around the world are eating better and living longer, but they are also moving less. This is contributing to the rise of diabetes, a condition that affects 422 million people and is fast becoming a major problem, especially in poor countries.
Two factors are critical for the successful treatment of diabetes patients. First is a correct diagnosis of the type of the disease, and second is the administration of the appropriate drugs.
A misdiagnosis and, consequently, the wrong treatment can cause many problems.
“If you label someone who actually has type 2 diabetes as type 1, they'll be left on insulin for the rest of their life when they don't need it," said Dr. Richard Oram of the U.K. National Institute for Health Research. "Even worse, if someone with type 1 diabetes is mislabeled as having type 2 diabetes, then they may not be treated with the insulin they need, and they may suffer life-threatening complications.”
A new, less expensive test, developed at the University of Exeter Medical School, measures 30 genetic variants in the patient’s DNA and calculates the risk for type 1 or type 2. Individual diagnoses can be completed with a commonly used test for antibodies.
Scientists are now trying to develop an even simpler DNA-based test that could be done with a smartphone app.
No more injections?
In the meantime, researchers in South Korea are developing a nanotechnology-based adhesive strip that takes away pain and stress of daily injections for diabetes patients.
“The device is a patch type that enables [diabetics] to monitor blood sugar levels via sweat without taking blood samples and injections, as well as to control glucose levels by injecting medication,” said Kim Dae-hyeong, a professor in the School of Chemical and Biological Engineering at Seoul National University.
The patch is studded with microneedles that painlessly enter subcutaneous tissue. When the connected chip senses that the level of glucose has risen above normal, a small heating element dissolves medication and releases it into the bloodstream.
Tests done on lab mice were promising, so scientists hope they will soon start testing the patch on humans. In this phase, experiments are still expensive, but scientists say the price will drop once it the patch is ready for mass production.
Vocabulary
misdiagnosis: 误诊,漏诊
新GRE写作备考方略
2011gre issue写作优秀实例:避免偏激
2011gre issue写作优秀实例:实用的意义
Issue写作常见问题及解决方法
gre作文备考资料:内在驱动和外在刺激
新gre写作:句式整理
issue写作:四种方法技巧
gre issue写作论据素材论证分析
2011gre issue写作优秀实例:新创意
2011gre issue写作优秀实例:直接和间接经验
2011gre issue写作优秀实例:礼节和典礼
突破gre argument写作具体规划
2011gre issue写作优秀实例:研究历史的好处
2011gre issue写作优秀实例:冒险与计划
2011gre issue写作优秀实例:多媒体教育
新gre写作须知:经典句型
gre写作具体规划
issue与argument实际考题与官方题目变化比较
突破新gre issue写作三大法宝
2011gre issue写作优秀实例:现代摄像机和印刷术
新gre作文题库argument:8种instroduction的区别
新gre写作须知:必备经典句型1
2011年11月5号新gre考试高频作文
新gre作文题库:issue写作三建议
新gre argument写作备考策略
新gre argument8种instruction解析
gre写作疑问句应用技巧
2011gre issue写作优秀实例:成功
新GRE issue写作破题方法揭秘
gre作文高分点评
不限 |
英语教案 |
英语课件 |
英语试题 |
不限 |
不限 |
上册 |
下册 |
不限 |